GemPharmatech Co (SHSE:688046) FCF Margin % : -57.20% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is GemPharmatech Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. GemPharmatech Co's Free Cash Flow for the three months ended in Mar. 2024 was ¥-89.9 Mil. GemPharmatech Co's Revenue for the three months ended in Mar. 2024 was ¥157.1 Mil. Therefore, GemPharmatech Co's FCF Margin % for the quarter that ended in Mar. 2024 was -57.20%.

As of today, GemPharmatech Co's current FCF Yield % is -3.00%.

The historical rank and industry rank for GemPharmatech Co's FCF Margin % or its related term are showing as below:

SHSE:688046' s FCF Margin % Range Over the Past 10 Years
Min: -21.22 Med: -4.04 Max: 76.75
Current: -21.22

During the past 6 years, the highest FCF Margin % of GemPharmatech Co was 76.75%. The lowest was -21.22%. And the median was -4.04%.

SHSE:688046's FCF Margin % is ranked better than
69.19% of 1045 companies
in the Biotechnology industry
Industry Median: -143.92 vs SHSE:688046: -21.22

GemPharmatech Co FCF Margin % Historical Data

The historical data trend for GemPharmatech Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemPharmatech Co FCF Margin % Chart

GemPharmatech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

10.10

-14.23

6.16

-16.33

-14.36

GemPharmatech Co Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial												-31.06	-13.32	-19.70	3.72	-57.20

Competitive Comparison of GemPharmatech Co's FCF Margin %

For the Biotechnology subindustry, GemPharmatech Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GemPharmatech Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GemPharmatech Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where GemPharmatech Co's FCF Margin % falls into.

GemPharmatech Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

GemPharmatech Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-89.327	/	622.187
	=	-14.36 %

GemPharmatech Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-89.858	/	157.087
	=	-57.20 %

GemPharmatech Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of GemPharmatech Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

GemPharmatech Co (SHSE:688046) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GemPharmatech Co Ltd (SHSE:688046) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032

Website

https://www.gempharmatech.us

GemPharmatech Co Ltd is a provider of?genetically engineered mouse?models?and services to global preclinical research and development communities. It specializes in developing animal models using cutting edge gene-editing technologies with a large collection of?cKO/KO (conditional knockout/knockout) mice, humanized mice, immunodeficient mice, and germ-free mice.

GemPharmatech Co (SHSE:688046) Headlines

No Headlines